Portal de Periódicos da CAPES

Introduction to “Screening for Endocrine Activity—Experiences with the US EPA's Endocrine Disruptor Screening Program and Future Considerations”

2014; Wiley; Volume: 101; Issue: 1 Linguagem: Inglês

10.1002/bdrb.21100

2472-1727

Sue Marty,

Carcinogens and Genotoxicity Assessment

Birth Defects Research Part B: Developmental and Reproductive ToxicologyVolume 101, Issue 1 p. 1-2 Introduction Introduction to “Screening for Endocrine Activity—Experiences with the US EPA's Endocrine Disruptor Screening Program and Future Considerations” Sue Marty, Corresponding Author Sue Marty Toxicology & Environmental Research and Consulting, The Dow Chemical Company, Midland, MichiganCorrespondence to: Dr. Sue Marty, The Dow Chemical Company, 1803 Building, Midland, MI 48674. E-mail: [email protected]Search for more papers by this author Sue Marty, Corresponding Author Sue Marty Toxicology & Environmental Research and Consulting, The Dow Chemical Company, Midland, MichiganCorrespondence to: Dr. Sue Marty, The Dow Chemical Company, 1803 Building, Midland, MI 48674. E-mail: [email protected]Search for more papers by this author First published: 07 February 2014 https://doi.org/10.1002/bdrb.21100Citations: 6Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES Marty MS, Carney EW, Rowlands JC. 2011. Endocrine disruption: historical perspectives and its impact on the future of toxicology testing. Toxicol Sci 120(S1): S93–S108. U.S. EPA. 2013a. Scientific issues associated with prioritizing the universe of Endocrine Disruptor Screening Program (EDSP) chemicals using computational toxicology tools. Washington, DC, January 29–31, 2013. Meeting materials available at: http://www.epa.gov/scipoly/sap/meetings/2013/012913meeting.html. Accessed January 12, 2014. U.S. EPA. 2013b. Endocrine Disruptor Screening Program (EDSP) Tier 1 screening assays and battery performance. Washington, DC, May 21–23, 2013. Meeting materials available at: http://www.epa.gov/scipoly/sap/meetings/2013/052113meeting.html. Accessed January 12, 2014. U.S. EPA. 2013c. Endocrine Disruptor Screening Program (EDSP) Tier 2 ecotoxicity tests. Washington, DC, June 25–28, 2013. Meeting materials available at: http://www.epa.gov/scipoly/sap/meetings/2013/062513meeting.html. Accessed January 12, 2014. U.S. EPA. 2013d. Weight-of-evidence: evaluating results of EDSP Tier 1 screening. Washington, DC, July 30–August 2, 2013. Meeting materials available at: http://www.epa.gov/scipoly/sap/meetings/2013/073013meeting.html. Accessed January 12, 2014. U.S. EPA. 2013e. Attachment F: calculations for paperwork burden and costs for data generation activities. ESP ICR Addendum (EPA ICR #2488.01; OMB #2070-[new]). Available at: http://www.reginfo.gov/public/do/DownloadDocument?documentID=403078&version=0. Accessed January 13, 2014. Citing Literature Volume101, Issue1Special Issue: Screening for Endocrine Activity – Experiences with the US EPA's Endocrine Disruptor Screening Program and Future ConsiderationsFebruary 2014Pages 1-2 ReferencesRelatedInformation